Lykka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug
Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of Pregabalin Gel 8% w/w for use in patients with Diabetic Neuropathic Pain.